Translating PrEP effectiveness into public health impact: key considerations for decision‐makers on cost‐effectiveness, price, regulatory issues, distributive justice and …
C Hankins, R Macklin, M Warren - Journal of the International …, 2015 - Wiley Online Library
Introduction The extraordinary feat of proving the effectiveness of oral pre‐exposure
prophylaxis (PrEP) in clinical trials in different populations in a variety of settings may prove …
prophylaxis (PrEP) in clinical trials in different populations in a variety of settings may prove …
Translating PrEP effectiveness into public health impact: key considerations for decision‐makers on cost‐effectiveness, price, regulatory issues, distributive justice and …
C Hankins, R Macklin, M Warren - African Journal of Reproduction …, 2015 - journals.lww.com
Introduction: The extraordinary feat of proving the effectiveness of oral pre-exposure
prophylaxis (PrEP) in clinical trials in different populations in a variety of settings may prove …
prophylaxis (PrEP) in clinical trials in different populations in a variety of settings may prove …
Translating PrEP effectiveness into public health impact: key considerations for decision-makers on cost-effectiveness, price, regulatory issues, distributive justice and …
C Hankins, R Macklin… - … Science: State-of-the-Art …, 2015 - search.ebscohost.com
Introduction: The extraordinary feat of proving the effectiveness of oral pre-exposure
prophylaxis (PrEP) in clinical trials in different populations in a variety of settings may prove …
prophylaxis (PrEP) in clinical trials in different populations in a variety of settings may prove …
Translating PrEP effectiveness into public health impact: Key considerations for decision-makers on cost-effectiveness, price, regulatory issues, distributive justice and …
C Hankins, R Macklin… - Journal of the …, 2015 - einstein.elsevierpure.com
Introduction: The extraordinary feat of proving the effectiveness of oral pre-exposure
prophylaxis (PrEP) in clinical trials in different populations in a variety of settings may prove …
prophylaxis (PrEP) in clinical trials in different populations in a variety of settings may prove …
[HTML][HTML] Translating PrEP effectiveness into public health impact: key considerations for decision-makers on cost-effectiveness, price, regulatory issues, distributive …
C Hankins, R Macklin, M Warren - Journal of the International AIDS …, 2015 - ncbi.nlm.nih.gov
Discussion In considering the role that PrEP can play in combination prevention
programmes, decision-makers must determine who can benefit most from PrEP, how PrEP …
programmes, decision-makers must determine who can benefit most from PrEP, how PrEP …
[PDF][PDF] Translating PrEP effectiveness into public health impact: key considerations for decision-makers on cost-effectiveness, price, regulatory issues, distributive …
C Hankins, R Macklin, M Warren - … Science: State-of-the-Art and …, 2015 - triple-x.org
Introduction: The extraordinary feat of proving the effectiveness of oral pre-exposure
prophylaxis (PrEP) in clinical trials in different populations in a variety of settings may prove …
prophylaxis (PrEP) in clinical trials in different populations in a variety of settings may prove …
[PDF][PDF] Translating PrEP effectiveness into public health impact: key considerations for decision-makers on cost-effectiveness, price, regulatory issues, distributive …
C Hankins, R Macklin, M Warren - … Science: State-of-the-Art and …, 2015 - europepmc.org
Introduction: The extraordinary feat of proving the effectiveness of oral pre-exposure
prophylaxis (PrEP) in clinical trials in different populations in a variety of settings may prove …
prophylaxis (PrEP) in clinical trials in different populations in a variety of settings may prove …
Translating PrEP effectiveness into public health impact: key considerations for decision-makers on cost-effectiveness, price, regulatory issues, distributive justice and …
C Hankins, R Macklin… - Journal of the …, 2015 - researchonline.lshtm.ac.uk
INTRODUCTION: The extraordinary feat of proving the effectiveness of oral pre-exposure
prophylaxis (PrEP) in clinical trials in different populations in a variety of settings may prove …
prophylaxis (PrEP) in clinical trials in different populations in a variety of settings may prove …
Translating PrEP effectiveness into public health impact: key considerations for decision-makers on cost-effectiveness, price, regulatory issues, distributive justice and …
C Hankins, R Macklin… - Journal of the …, 2015 - pubmed.ncbi.nlm.nih.gov
Introduction The extraordinary feat of proving the effectiveness of oral pre-exposure
prophylaxis (PrEP) in clinical trials in different populations in a variety of settings may prove …
prophylaxis (PrEP) in clinical trials in different populations in a variety of settings may prove …
[PDF][PDF] Translating PrEP effectiveness into public health impact: key considerations for decision-makers on cost-effectiveness, price, regulatory issues, distributive …
C Hankins, R Macklin, M Warren - 2015 - Citeseer
Introduction: The extraordinary feat of proving the effectiveness of oral pre-exposure
prophylaxis (PrEP) in clinical trials in different populations in a variety of settings may prove …
prophylaxis (PrEP) in clinical trials in different populations in a variety of settings may prove …